11:05 AM May 25, 2018

HKEX’s on-demand experts

The Hong Kong stock exchange is well aware its investor base is new to the high-risk, high-reward nature of its newly hatched biotech chapter and has no qualms about admitting its own lack of...

6:09 AM May 25, 2018

Model alliance

An FDA pilot program on model-informed drug development could generate the information FDA needs to fulfill a commitment under PDUFA VI and answer a big industry ask: more clarity on the agency’...

6:01 AM May 25, 2018

Patients at the core

With excitement mounting for the seven hemophilia gene therapies in the clinic, the National Hemophilia Foundation wanted to avoid a scenario in which patients, physicians and payers had no good...

5:36 PM May 24, 2018

Peptides step up

New screening platforms and synthetic approaches could finally solve some of the longstanding hurdles to turning antimicrobial peptides into therapeutic candidates to combat antibacterial...

4:17 PM May 24, 2018

Bias-less bispecifics

Taking a leaf from the small molecule playbook, cancer play Merus N.V. is bringing unbiased screening to the bispecifics space. The biotech is betting the approach can discover bispecific...

1
2
3
4
5

Latest News

4:20 PM May 25, 2018

China rare disease list could promote R&D, regulatory filings

Five Chinese government agencies, including the State Drug Administration and the National Health...

3:48 PM May 25, 2018

NEA promotes Chang, Behbahani

New Enterprises Associates promoted Carmen Chang and partner Ali Behbahani to general partner. Chang, a...

3:48 PM May 25, 2018

Management tracks: ISA, ImCheck, ArQule

Immunotherapy company ISA Pharmaceuticals B.V. (Leiden, the Netherlands) promoted CBO Gerben Moolhuizen to...

3:08 PM May 25, 2018

Eidos, Avrobio propose NASDAQ IPOs

Eidos Therapeutics Inc. (Palo Alto, Calif.) and Avrobio Inc. (Cambridge, Mass.) proposed NASDAQ IPOs on...

2:59 PM May 25, 2018

Activating astrocytes to enhance memory

In a paper published in Cell, researchers at The Hebrew University of Jerusalem showed that activating...

2:21 PM May 25, 2018

Chinese investors launch HPV JV

Shanghai Institute of Biological Products Co. Ltd. (Shanghai, China), 6 Dimensions Capital and Renxian...

2:08 PM May 25, 2018

Immunoproteasome company Kezar files for $80.5M IPO

Kezar Life Sciences (South San Francisco, Calif.) filed Thursday to raise $80.5 million in an IPO on...

1:07 PM May 25, 2018

Venter retiring from Human Longevity

J. Craig Venter said in a tweet May 24 that he is retiring from genomics company Human Longevity Inc. (San...

11:52 AM May 25, 2018

Monitoring the gut with engineered biosensor

A Science study led by Senti Biosciences Inc. (South San Francisco, Calif.) co-founder and CEO Timothy Lu...

11:35 AM May 25, 2018

Imfinzi shows OS benefit in non-progressing NSCLC trial

AstraZeneca plc (LSE:AZN; NYSE:AZN) said Imfinzi durvalumab improved overall survival vs. placebo, meeting...

10:53 AM May 25, 2018

AI-based diagnostic for wrist fractures gets FDA green light

FDA has permitted marketing of OsteoDetect, an artificial intelligence-based software product from Imagen...

10:05 PM May 24, 2018

Transplant company Magenta plans $100M listing

Stem cell transplant company Magenta Therapeutics Inc. (Cambridge, Mass.) filed to raise up to $100...

7:27 PM May 24, 2018

Anti-infectives play Iterum raises $80M in IPO

Iterum Therapeutics plc (NASDAQ:ITRM) raised $80 million late Thursday through the sale of 6.2 million...

4:05 PM May 24, 2018

FDA approves BioMarin's phenylketonuria drug

FDA approved Palynziq pegvaliase-pqpz from BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to treat...

3:58 PM May 24, 2018

Lawmakers introduce direct-to-consumer rebate bill

Reps. Doug Collins (R-Ga.) and Vicente Gonzalez (D-Texas) introduced a bill that would direct health plans...

3:33 PM May 24, 2018

Striatal dopamine signaling regulates glucose metabolism

Researchers at Academic Medical Center (AMC) found that dopamine signaling is a key regulator of systemic...

3:16 PM May 24, 2018

Antengene fills pipeline with Karyopharm deal

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) granted cancer company Antengene Corp. (Shanghai, China)...

2:58 PM May 24, 2018

Imbruvica, Gazyva combo meets in first-line CLL

AbbVie Inc. (NYSE:ABBV) said Imbruvica ibrutinib plus Gazyva obinutuzumab met the primary endpoint of...

2:33 PM May 24, 2018

Shifting Medicare Part B drugs to Part D saves nothing, CBO says

A Congressional Budget Office analysis of the Trump administration’s FY19 budget proposal concludes that...

2:28 PM May 24, 2018

miRNA-targeted circular single-stranded DNA to treat cancer

A Nankai University-based team developed a small circular single-stranded DNA molecule that inhibits...

Down Up